Modular Medical, Inc. (MODD) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Modular Medical, Inc. (MODD) Healthcare & Pipeline Overview

Modular Medical, Inc. is a development-stage medical device company dedicated to revolutionizing insulin delivery for diabetes management. Focusing on innovative design and technology, Modular Medical aims to increase insulin pump adoption within the competitive diabetes care market. The company is headquartered in San Diego, California.

What Is the Investment Thesis for MODD?

Modular Medical, Inc. presents a speculative investment opportunity given its development-stage status and focus on the competitive insulin pump market. The company's success hinges on the successful development, regulatory approval, and commercialization of its insulin pump technology. Key value drivers include the potential for increased market share through enhanced pump adoption and technological differentiation. Upcoming catalysts include clinical trial results and regulatory submissions. Potential risks include competition from established players, technological hurdles, and the need for additional capital to fund operations. Investors should carefully consider these factors and the company's financial position before making investment decisions.

Based on FMP financials and quantitative analysis

MODD Key Highlights

Modular Medical, Inc. is a development stage company, indicating a high-risk, high-reward investment profile.

• The company's focus on insulin pump technology targets a large and growing diabetes market.
• The company is based in San Diego, California, a hub for medical device innovation.
• The company has 39 employees, reflecting its current stage of development.
• The company's market capitalization is $5.57M, indicating its small-cap status.

Who Are MODD's Competitors?

MODD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are MODD's Key Strengths?

Innovative insulin pump design.

• Focus on enhancing user experience.
• Potential to disrupt the diabetes device market.
• Dedicated team with expertise in medical device development.

What Are MODD's Weaknesses?

Development stage company with no current revenue.

• Limited financial resources.
• Dependence on successful product development and regulatory approval.
• Small market capitalization.

What Could Drive MODD Stock Higher?

Clinical trial results for the insulin pump technology.

• Regulatory submissions to the FDA for market approval.
• Development of strategic partnerships with healthcare providers.
• Securing additional funding to support research and development.

What Are the Key Risks for MODD?

Financial-distress signal — its Altman Z-Score of -18.29 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
• Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
• Competition from established players in the insulin pump market.
• Technological hurdles in product development.
• Regulatory delays or rejection of market approval.
• Dependence on securing additional funding to sustain operations.
• Market acceptance of the company's insulin pump technology.

What Are the Growth Opportunities for MODD?

• Expansion into the continuous glucose monitoring (CGM) market represents a significant growth opportunity for Modular Medical. Integrating CGM technology with its insulin pump could create a closed-loop system, enhancing the user experience and improving glycemic control. The global CGM market is projected to reach $10.7 billion by 2027, offering a substantial addressable market for Modular Medical. This expansion would require significant investment in research and development, but could provide a competitive edge.
• Geographic expansion beyond the United States offers another avenue for growth. The prevalence of diabetes is increasing globally, particularly in emerging markets. Adapting its insulin pump technology to meet the specific needs and regulatory requirements of different countries could unlock new revenue streams for Modular Medical. This expansion would require careful market analysis, strategic partnerships, and compliance with local regulations. The timeline for international expansion is dependent on regulatory approvals and market entry strategies.
• Strategic partnerships with diabetes clinics and healthcare providers can accelerate market adoption of Modular Medical's insulin pump. Collaborating with key opinion leaders and healthcare professionals can enhance credibility and facilitate product awareness. These partnerships can also provide valuable feedback for product development and improvement. The timeline for establishing strategic partnerships is ongoing, with the goal of building a strong network of advocates for Modular Medical's technology.
• Development of a next-generation insulin pump with advanced features, such as artificial intelligence-powered algorithms and personalized dosing recommendations, could attract a wider customer base. Incorporating these features would require significant investment in research and development, but could position Modular Medical as a leader in diabetes technology. The timeline for developing a next-generation insulin pump is estimated to be 3-5 years, contingent on technological advancements and regulatory approvals.
• Exploring alternative funding mechanisms, such as government grants and venture capital, can provide the necessary capital to support research and development efforts. Securing additional funding is crucial for advancing its insulin pump technology and bringing it to market. The timeline for securing additional funding is ongoing, with the goal of diversifying its capital base and reducing reliance on debt financing. Successful fundraising efforts would enable Modular Medical to accelerate its growth plans and enhance its competitive position.

What Are MODD's Competitive Advantages?

• Proprietary technology in insulin pump design.
• Potential for strong brand reputation through user-friendly and effective products.
• Intellectual property protection through patents and trademarks.

What Does MODD Do?

Modular Medical, Inc., headquartered in San Diego, California, is a development stage medical device company concentrating on the design, development, and eventual commercialization of advanced insulin pumps. The company's core mission revolves around leveraging technology to make insulin pump therapy more accessible and appealing to a broader segment of the diabetes population. Founded with the vision of addressing the unmet needs in diabetes management, Modular Medical is committed to creating user-friendly and technologically advanced solutions. The company's primary focus is on developing insulin pumps that are designed to enhance user experience, improve adherence, and ultimately lead to better health outcomes for individuals living with diabetes. While still in the development stage, Modular Medical is actively working towards bringing its innovative insulin pump technology to market, positioning itself as a potential disruptor in the diabetes device landscape. The company's efforts are centered on rigorous research, development, and testing to ensure the safety and efficacy of its products before commercial launch. With a dedicated team and a clear vision, Modular Medical aims to play a significant role in advancing diabetes care and improving the lives of those affected by this chronic condition.

What Products and Services Does MODD Offer?

• Designs and develops insulin pumps for diabetes management.
• Focuses on enhancing insulin pump adoption through innovative technology.
• Aims to improve the user experience for individuals with diabetes.
• Conducts research and development to create advanced insulin delivery systems.
• Seeks regulatory approvals for its medical devices.
• Plans to commercialize its insulin pump technology in the diabetes marketplace.

How Does MODD Make Money?

• Develops and manufactures insulin pumps.
• Seeks to generate revenue through the sale of insulin pumps and related accessories.
• May explore subscription-based models for ongoing support and supplies.

What Industry Does MODD Operate In?

The medical device industry, particularly the diabetes care segment, is characterized by continuous innovation and increasing demand. The market for insulin pumps is driven by the rising prevalence of diabetes and the growing preference for advanced drug delivery systems. Modular Medical operates in a competitive landscape dominated by established players with significant market share. The company's success depends on its ability to differentiate its products through technological innovation, user-friendly design, and cost-effectiveness. The industry is also subject to stringent regulatory requirements and evolving reimbursement policies.

Who Are MODD's Key Customers?

• Individuals with type 1 and type 2 diabetes who require insulin therapy.
• Healthcare providers who prescribe insulin pumps to their patients.
• Diabetes clinics and hospitals that offer insulin pump therapy.

Over the past six months, Modular Medical, Inc. insiders filed 20 SEC Form 4 transactions — 0 sales and 20 purchases. On net that is roughly 19K shares acquired (about $67K) — insiders putting money in tends to read as conviction.

Wall Street analysts project Modular Medical, Inc. revenue of about $3.2M for fiscal 2026, with EPS near $-11.70.

Modular Medical, Inc. has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 4.8% below estimates on average.

Modular Medical, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -18.29 places it in the distress zone, a signal of elevated financial risk.

Modular Medical, Inc. (MODD) Valuation Context

Valued at $5.57M, MODD is classified as a micro-cap stock. Relative to its peer group, MODD's quantitative score of 27/100 is below the peer average of 43/100.

Company Profile

Modular Medical, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in San Diego, US. The company is led by CEO James E. Besser. MODD has traded publicly since 2022.

MODD Financials

MODD Latest News

MODD Analyst Consensus

MODD MoonshotScore

Common Questions About MODD (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources